. >> two months later, investigators found cliff merck's gun.as in the possession of a man, whom we'll call dan jones, at the time he was arrested on a drug charge. it was easily identifiable since cliff's initials had been carved into the handle. >> that was cliff. he had his name on practically everything that he owned. he'd take some kind of an etcher and etch his initials on it, you know, just for identification. >> jones denied any involvement in the murder and said he bought the gun from an acquaintance, robert cowan, a man well known to law enforcement. >> he had no occupation and he supported himself by stealing, robbing houses, stealing from people outside of restaurants and that type of thing. he had a long record of robberies and use of narcotics. >> robert cowan also had a partner in crime, his brother gerald. >> the brothers were involved in criminal activity, a lot of small-time stuff, public drunk, a lot of narcotics usage, some assaults. >> forensic scientists tested cliff's gun to see if it was the one used in his murder. the gu

merck to focus on innovation.es innovation look like at merck? >> well, for merck, coming forward with transformational medicine. a recent example is our new investigational medicine for cancer. it's one of the first in a series of what are called immunotherapies for cancer. it defeats the body defeat the tumors. that's the kind of thing a company like merck exists to do. >> how do you decide which drugs are going to be in the pipeline for long-term development? >> first of all, those decisions are made by our very capable research scientists. they're not made in the first instance by made. and that's a good thing for people, that they're investors as well as patients being made by those very able people. but generally speaking, where america tries to go with its research dollars, we look for the intersection of unmet medical need and scientific opportunity. so we want to be in those areas like cancer, like alzheimer's, like hiv, where there's great unmet medical need around the world, a need for better therapy, a

we will speak to the merck cfo. ♪ >> good morning and welcome back. bring you a picture of the equities market 30 minutes into the session. the dax is up 0.25%. german retail sales month on month at 2.9% expected to come in at less than half of 1%. the dax is higher, the ftse 100 is higher. let's get into some of the indices and bring some top stories with anna edwards. >> let's talk about barclays. the details this morning coverage and it is down. another mention and the ceo is getting his first bonus since he took the job in charge of what is the uk's number two bank. he took over 2.5 years ago. just trying to take it more toward the retail side of things. that continues. he told my colleague earlier, does the editing jenkins off course every part of his business must deliver on equity targets. -- and that is anthony jenkins of course, every part of his business must deliver on equity targets. quite crucial to the results of glencore and net profits beat. what set it apart from the few -- pure mining it has the business which itself commodities such

merck is like -- it should be st. merck. we always thought of merck as the gold standard.ould be making a comeback. they obviously think, they're buying back tock. but it's been a total dog. >> it has been. >> yeah, moved up but -- >> everybody believes the best opportunity for use some of their cash is buying back stock. >> we don't want tuna with good taste. we want good-tasting tuna. give us the alzheimer's drug we thought we'd get. give us something from the schering-plough deal we thought we'd get. we need results. re we need results. >> opening bell after this. hey, girl. is it crazy that your soccer trophy is talking to you right now? it kinda is. it's as crazy as you not rolling over your old 401k. cue the horns... just harness the confidence it took you to win me and call td ameritrade's rollover consultants. they'll help with the hassle by guiding you through the whole process step by step. and they'll even call your old provider. it's easy. even she could do it. whatever, janet. for all the confidence you need td ameritrade. you got this. [ male announcer ] your

merck is -- my wife works as merck. let's get that out there. i want to make that point. i think pfizer in the space is much more interesting at these levels. >>> all right. twitter topping the tape today surging 6% closing above $50 for the first time this year. does the social stock still have more room to run? we'll debate that. >>> netflix getting some love from two wall street firms. the company goes live in australia and new zealand. we'll tell you the best way to play the streaming space. >>> in one month, one month, the apple watch goes on sale. do you buy the stock now or wait to see if people buy the watch? we'll tell you how the stock usually trades around product releases coming up on "fast." friday night, buddy. you are gonna need a wingman. and my cash back keeps the party going. but my airline miles take it worldwide. [ male announcer ] it shouldn't be this hard. with creditcards.com, it's easy to search hundreds of cards and apply online. creditcards.com. >>> we got this whole thing all wrong. don't worry about declining commodity prices. in fact, my botto

merck's board approved an additional $10 billion stock buyback program. they reported 4th quarter sales fell 7% with foreign exchange accounting for the majority of the drop. earlier on tuesday they halted a study of a nu skin cancer drug following positive clinical trial results. shares rose 1.5% and in yesterday's trade they closed down by .2%. >> still to come here on worldwide exchange why a cheese and ketchup combo could be a match made in merger heaven. later reports kraft may be bought by the private equity owner of heinz, coming up in a couple of minutes. kraft could soon add another of the world's top well-known brands to its line-up. heinz ketchup. landon joins us from cnbc hq to piece together the story. >> they're in talks to be bought by 3g capital. it's unclear whether they would do the transaction alone or because of the size will team up with a partner. they worked with warren buffet to buy heinz for $23 billion in 2012. buffet said he would welcome the opportunity to work with 3g again. if it buys kraft it can merge it with heinz. in addi

what he was also saying is it gets this big lead over merck and roche potentially.ck and roche close on the heels and could get potentially broader or different approvals. it's interesting to see how that works out. another implication to this, we're continually seeing drugs get approved early at the fda. of course that's good news for the entire industry. wells fargo actually saying that there's a potential for vertex, a cystic fibrosis combo. both of these immunotherapy drugs are aproproved early. this a record early approval for lung cancer. vertex, a cystic fibrosis drug was approved early, kalydeco. looking at the overall trend and looking forward to whether we may see more early approvals, melissa. >> let's pivot, meagan. i think what most people were puzzled about if they were puzzled about this deal at all is the 39% premium on the deal. what does this do for the other potential targets? >> yeah, you make the perfect point, so the questions here today was why is abvie paying so much for half the drug? paying $21 billion. you're seeing abbvie under pressure,

a strategic collaboration with merck. that's the german america, not the u.s. merck.ice move up there. back to you. >> thanks so much. just a quick comment steve and josh if you would on what bob was showing about the energy names. are investors going to be kick themselves a year from now this if they didn't buy these names today? >> i think the path of least resistance rate knew is energy going lower because storages fault going to come into the market. they'll release a lot of energy into the market. so i think it's a crap shoot. >> still too early? >> it's still too early. the stocks have rallied. i don't think oil is sustainable right here. >> what i keep noting as oil makes new lows in the price, the stocks don't. they're not willing to step up and buy the low quality. they want cash flows, dividends. they don't care. they want to be in them. until that changes, i think it's easy to buy them on down days. if you want to take profits on days like today, you certainly can. i'm investing. >> the search for yield has some investors looking at alternative ways to make

they're going to gilead and merck. getting out of qualcomm. opportunities in terms of the same names within sectors. >> so how do we use this data? if we're seeing that institutions are making the moves 12 to 24 months ahead. does that mean that the trade is on for the next 12 to 24 months potentially? or that the trade's over? >> no, that means the trade is still to come if you're a retailer. all right. the institutional community, they're a couple steps ahead. these are the names that retail sechblgly going to catch up to. people watch shows like this and eventually catch up to guys like you are doing. eventually they get in the stocks, at this point, it's a step ahead. these are the names to watch out for going forward because you don't to want get on the wrong side of that type of a trade when people have moved their money up. >> going to leave it there, thank you. aka, ice. >> why -- >> very short. >> i guess because it could go on forward. >> people don't get tired of eric. more of eric, maybe less of vanilla ice. >> turn the channel whe

mark: on the show tonight, why clinton won't back down and what does the merck ad say. but first, america's most eloquent politician, benjamin netanyahu. he's given more interviews to u.s. journalists than anyone else. he was asked about the pursuit of a two-state solution. >> that pursuit has been the foundation of policy in the region, not just in this administration but the previous administration as well. i would point out that this policy is one that's strongly supported by democrats and republicans on capitol hill system of when prime minister netanyahu indicated a weakness in his commitment, and i think that's putting it charitably indicated his weakness to the two-state solution he was indicating a difference of opinion not just with president obama but with the policy purr pseudoby president bush and the policy that's strongly supported by democrats and republicans in the united states congress. mark: it's clear that wasn't an aberration yesterday. what's the strategy to change netanyahu's behavior and could it work? campbell: i don't think they want to change

merck's founding document promises life, liberty, and the pursuit of happiness. iran's founding document pledging death, tyranny, and the pursuit of jihad. and iran is charging into the void to do just that. iran's goons in gaza it's lackeys in lebanon, it's revolutionary guards in the golan heights are clutching israel with three tentacles of terror. backed by iran assad is slaughtering syrians. backed by iran shia militias are a rampaging through iraq. houthis are seizing control of yemen, backed by iran. along with the straights, that would give iran a second choke point on the world's oil supply. just last week iran carried out a military exercise blowing up a mock u.s. aircraft carrier. that's just last week. while they are having nuclear talks with the united states. but unfortunately for the last 36 years, iran's attacks against the itself have been anything but mock and the targets have been all too real. iran took dozens of americans hostage in tehran, murdered hundreds of american soldiers marines in beirut, and was responsible for killing and maiming t

cheryl: you like merck? >> i do. 10 billion-dollar buyback. they are hitting on all cylinders. they have a medical no, ma'am drug came out of trials. they stopped trials because it was doing so well. these are areas, this company really has done well. it had trouble back in early part of 2000. had difficult with vioxx but now a good company to invest in. like you said with obamacare, these, this health care sector is sort of running, no end in sight. david: jamie, keeping with our conversation we were having with todd about american consumers and so many americans living paycheck to paycheck, why would american express be bun of our picks? if you're concerned about discretionary spending, and there are reasons to be concerned when you look what is happening in the economy, why are you for american express given that as a background? >> i like american express. i think there has been a lot made of the costco news. when american express lost the deal with costco and went to mastercard visa type arrangement, people have really sold that stock down. i think american express, it ser

he is long breast ol, long j & j, eli lelly and merck.e wake of the nasdaq hitting 5,000, the founder of the failed globe.com steffan tells us it's different. next up, final trades. we're going to solar stocks. you should be watching. back after this. [ female announcer ] who are we? we are the thinkers. the job jugglers. the up all-nighters. and the ones who turn ideas into action. we've made our passions our life's work. we strive for the moments where we can say, "i did it!" ♪ we are entrepreneurs who started it all... with a signature. legalzoom has helped start over 1 million businesses, turning dreamers into business owners. and we're here to help start yours. turning dreamers into business owners. at ally bank no branches equalsit's a fact.. kind of like mute buttons equal danger. ...that sound good? not being on this phone call sounds good. it's not muted. was that you jason? it was geoffrey! it was jason. it could've been brenda. [ male announcer ] at northrop grumman, we've always been at the forefront of advanced electronics. p

for example strong earnings reports from merck and from a chemical company. german retailers are happy reporting a strong increase of sales at the beginning of this year. low energy prices and the general minimum wage which was introduced here in germany. the dax did not really profit from this. only for a short moment, it reached another record high. on the high level the dax had reached before, many people had been nervous here and many expected a correction downward. >> we can stay for a closer look at the number -- the dax finishing at -- the euro stoxx 50 down as well. the dow jones up by more than .4%, still above 18,000. the euro up slightly higher against the greenback. >> this is commodity prices continue to remain low. with prices at the pump continuing to turn downward for the foreseeable future, play of drivers are looking at getting into a new set of wheels. >> for all the talk of electric, self driving cars, it's the ordinary bread-and-butter models stealing the show in geneva this week. >> germany's volkswagen has grabbed the title of car of th

both merck and santa fooe have developments and important as dengue cases risen 30 fold in the last 50 years. santa fe reported. florida keys looks to test the bugs in the u.s. the experts look ahead to next year when the olympics land in rio daijhee rio de janeiro, brazil. oxy tech received initial approval to receive genetically modified bugs there, among many efforts to control the mosquito population as the olympics bloom. i'm meg tirrell in the florida keys. >> that's "nightly business report" for tonight. this is the time of year your public television station seeks your support. >> and on behalf of your public tv station, thank you. we'll see you to explore new worlds and new ideas through programs like this made available for everyone through contributions to your pbs station from viewers like you. i'm going to teach you 7 steps for how to get older without aging. dr. christiane northrup, visionary pioneer and a leading authority on women's health, now takes the topic of aging and turns it on its head. i want you to dance through time reject the notion that age causes a decreas

. >>> and merck's board of directors authorized a new $10 billion stock repurchase program that brings its total buyback program to nearly $12 billion. announcement sent shares initially higher in after hours trading. the stock finished the regular session slightly lower to $58.63. >>> for the better part of a decade, a joint venture between boeing and lockheed martin had a virtual monopoly on supplying rockets to the government. it's a significant challenge fromon spacex spac. jane wells was given unprecedented access to the rocket facility in decatur, >> reporter: >> this is a very first stage of building a rocket. >> reporter: inside america's largest rocket company, they have never been busier. >> this is your spray on foam installation that's actually sprayed in that booth and then they come in here and shave it off. >> reporter: ula, a joint venture of boeing at lockheed martin makes big rockets but it's trying to make the price tag smaller. >> i don't u how ula is as expensive as they are. >> reporter: at a congressional hearing last week the president of ula rival space x criti

. >> reporter: upcoming into the eu leader in brussels elects and germany's chancellor, angela merck l, could have a solution for gree repayment in salary bills at the end of this month and beyond. those who hoped were dealt a swift blow earlier on. angela merkel said there will be no solution. it comes down to the individual financial ministers to reach a deal. the second blow came in the form of reports suggesting the european central bank was going to become even more tough on the greek banks. a trigger for stressing the economy. we thought the reaction in the greek debt market yield significantly higher over the course of the session. both leaders have their hands tied by public sentiment. even in the last few weeks, one recent survey suggesting 59% of the population willing to see greece lead the euro zone. if we look at greece division he's bound by the promises he made to the greek people we've been talking about these for weeks but also the deal that he signs just over a month ago when he said without reforms, without implementation of the reforms, there will be no cash. this

a lot of companies, such as adidas, barclays, merck, scheduled to report.e will also be getting the latest information from u.s. personal spending. it probably fell in february, reflecting part of the drop we are seeing in gasoline purchases. it shows incomes -- u.s. manufacturing probably held close to a one-year low in february as falling oil prices limited demand and export markets remain weak. by wednesday, we will get the latest from the beige book. that is a snapshot of the economy in 12 separate bank regions. washington, d.c., the supreme court will be waiting in on obama care. the federal reserve will release results of his latest bank stress test. on friday, the monthly jobs data. u.s. companies probably added about 235,000 workers to their payrolls in february. i am su keenan, bloomberg tv news. >> this is the equity position of the moment. we have a market in seoul. south korean stocks samsung announcing a new smart phone. here in hong kong, a very brief look. we are looking for what is going on in the afternoon in tokyo. tokyo stocks reopen in j

that is the case for a company like merck. olivia: scarlet fu chief rockets correspondent.esla, the forward pe is $275. for ford cruz-- $10. there is the difference between how investors view this companies. i got a look at a ford the focus rs. the only one in this country, one of 12 performance vehicles ford is rolling out. steve odell is ford's executive vice president of global marketing sales. 4 unveiled so far, the mustang gt350 ford gt, the new f150 raptor. is this a push to change the company's image? steve: you've seen the bandwidth of the products ford can offer, from a fiesta in south america up to the 750. matt: i was looking at the truck coming out in may. produced in ohio with a diesel engine. a huge range. you seem to be focused on the sporting aspect of the performance aspect why? steve: ford has a history of sporting. the company ignited by henry winning the race years ago. it is part of our dna. you were interested in the drift mode. matt: it can change the damping regulation, mechanical torque vectoring. steve: it allows you to over steer. olivia: is this

and the president and cio of merck investment -- what's the rhetoric on the ground right now?> greece is not on the official agenda. instead after they finish the first day of talks on things like energy union and relations with russia related to the ongoing conflict in ukraine there will be a site meeting between mario draghi, angela merkel, the french president and other high level officials. there will be a chance to air some of the issues and, if everything goes well, possibly pave the way for more talks ahead. alix: who is the m most important present -- most important person the greek president has to meet with? >> last night, they passed a subsidy package and said forget about everything. we don't care what you guys are doing it. alix: this is significant because official creditors that don't try to pass any package that would give subsidies to anyone until we could work this out and they approved it anyway. >> no one died. >> obviously, but they are getting away with everything. you only put in place conditions if there are consequences for not meeting them. if i were

mark: on the show tonight, why clinton won't back down and what does the merck ad say. first, america's most eloquent politician, benjamin netanyahu. he's given more interviews to u.s. journalists

. >> they will win four particulars to six flags merck. and it is easy to become the next fan of the day. >> fill out the page and still out the entire entry forms. >> this is tracking the snow to the north. and knowing in places like burke and shrinkfieldfield. and this is towards the east and west. and parts of northern maryland. and northern virginia. >> we will have snow on and off. and into the afternoon. we will have the friday forecast in just dunkin's new vanilla coffee creamer really tastes like it has more vanilla flavor. how is that even possible? boom! [ laughter ] oh, it's possible. introducing dunkin's new coffee creamer. extra vanilla flavor you can really taste. . >>> he have an update on the yellow alert day much we have rain falling in most of the immediate metro area and wet snowflakes mixing in and west of the beltway. we have wet snow starting to accumulate on grassy surfaces. it is holding steady and we will see the mix of rain and snow through noon and just plain rain and it is going to wash away any of the accumulat

. ♪ merck: welcome back to the second half-hour of open bottom line" -- of "bottom line" on bloombergision. i'm mark crumpton. let's check the price of crude oil and the close of floor trading here in new york city. you see on your screen crude finishing the day of 1.8% at 47.39. starbucks has backed away from the first stage of its controversial effort to spur discussion on race relations. employees will no longer right words "great together" -- "race together on cups. the company will still hold employee forums and commit to adding stores in urban communities. one of the iconic brands in baseball has been sold. the finnish company and their sports i thought we slugger, the bat maker. the price tag, $70 million, all cash. they own a number of sporting goods brands, including wilson. turning to march madness, now down to the sweet 16 in a number -- in a pair of number two teams that lost on sunday. wichita beat kansas the first meeting between the two schools in 25 years. wichita state next depomed, notre dame. -- next opponent, notre dame. the spartans will play oklahoma in the regio

merck lee. -- merkley. ms. baldwin. mr. kaine. mr. king. mr. chairman. the yeas are 10 the nays are 12. mr. enzi: the amendment fails. the next amendment, senator crapo's amendment. mr. crapo: i yield to senator warner on this. mr. warner: we should not be using the fees which should be going to support our housing industry as a piggy bank for other programs. it's rare to see we've got bankers, civil rights groups, all aligned. s that fiscally responsible amendment and i urge passage. mr. enzi: any objection to a voice vote? seeing none. those in favor say aye. those opposed, no. carried. next one is the murray amendment. ms. murray: this is the amendment that takes the deficit neutral reserve fund provided in section 307 and expands it to allow us to use it for drastically needed issues for our veterans and service members including providing additional job training programs, specialty services importantly caregiver support that i think we all know many of our veterans, aging veterans, need as well, allows them to stay in their homes and work with v.a.'

i happen to like that space because a lot of people feel merck overpaid. are something people are circling back to. that's my thinking that the super bugs must be killed. let's take one more. junior in high home state of new jersey. >> reporter: as good as class a. >> both classes are terrific. i like berkshire, i think they should be bought because you have to get deals and can't do it yourself. that is ladies and gentlemen, the conclusion of the lightning round. >> the lightning round is sponsored by td ameritrade. >> i'm always telling you to do your own homework especially during earnings season and i'm not soupy sales but couldn't resist. ♪ >> in case you have a one-off issue causing the market to misjudge results entirely and that's what happened to cramer faf williams smoem ma even though the company delivered inline earnings the revenues came in a bit light. oh my life savers. >> boo-yah, first time caller mr. cramer. >> why don't i go to frank in california. [ crickets chirping ] >> frank? >>. >> caller: yes. >> frank, you're up. >> caller: okay h

>> i think it might be redunn dan system i think merck or pfizer would be the next to go.placing them, both really good companies. just getting rid of redundancy, replacing it with amgen, roche, more of a biotech name to spread out diversification in the dow. liz: larry, i agree with you. that is interesting. we have big microsoft, cisco, intel names that, i wouldn't say they're redundant. but they're all technology. adam, what do you think? >> go with what the first guest said, you have to pick ge. even though a big market cap -- liz: you can't remove ge from the dow. >> right you can't lose at&t after 100 years. liz: there you are. >> ibm, despite they're trading $158 a share. because as the dow starts to shift to these new tech companies in this new economy started back in 1999, ibm is recreating itself. it become as software company. will not be able to compete with likes of google and apple. liz: i think travelers. i think travelers is vulnerable. it has $34 billion market cap and is 05 share price. that is my two cents. keeping your enemies close? amazon opening a st

nemtsov was murdered less than two weeks ago and the investigation into the case seems to be getting merck yer. two chechen men have been charged. boris nemtsov's daughter said vladimir putin is responsible for her father's death. >> keep power in kremlin. >> all the independent media. >> this is not an election. this is a special election. this is manipulation and fraud. >> reporter: for a decade boris nemtsov was one of russia's most high-profile voices of dissent. last month that voice was silenced within sight of the kremlin. his daughter zhanna has no doubt who she believes is responsible. >> he was a threat to putin. >> reporter: it's putin you blame for his death? >> politically, yes. politically. >> reporter: we traveled to northern italy to meet miss nemtsov. she and her father used to come here on family holidays. on the night of the killing, zhanna was in her moscow apartment and her mother was in the next room. >> i was asleep. the room that my mother was yelling and crying and i saw that somebody had attacked her. i came into her room and asked her what was going on and she to

merck, how crucial it is that these negotiation between germany and greece come to a resolution. >> it'sery crucial to greece. whether it is crucial for the rest of europe is up for debate. i happen to be in the camp that says because the financial institutions no longer hold the greek debt but now it's the imf, and the european union, that if greece were to default, it isn't such a big deal. clearly there would be ripple affects, but the attitude in northern europe says we can stomach a greek default, and the obligation, of course, is that weakens greece's negotiating hand, because greece is still of the position that it would be a disaster for europe and the rest of the world. >> what does it say about the greek position being hey, nazi germany took a lot of our people and therefore they should pay reparations and other things that greece seems to be talking about. >> well the greek prime minister today back pedalled from that and then said no we don't want reparation payments. angela merkel made it clear that legally and politically these issues are resolved. but there were many testy

first, merck announcing a $10 billion buy back. that's on top of the previous buy back.they had some true data. some charitable trust. surprised it wasn't up more in the session. it will go up tomorrow. second, sonic, the restaurant chain reported an excellent number. that stock has been way up. i think it can go still higher provided that gasoline stays down here. these were pieces of good news in a dismal day except for the netflix and the google and the facebook. i promise to find a bull market somewhere. i'm jim cramer. see you tomorrow! >> look, scarface was a gangster, but that [bleep] was fiction. [bleep] charles cosby -- that [bleep] a living legend. that [bleep] the real scarface [bleep] that dude was flipping down. >> ♪ i'm the godfather, head honcho ♪ ♪ married to the game like griselda blanco ♪ ♪ put the keys in the closet in my condo ♪ ♪ bulletproof vest on my chest like poncho ♪ >> ♪ incredible ♪ >> ♪ i clap like an encore ♪ ♪ for the right price, i'll turn you to a john doe ♪ ♪ went from a bronco to the bentley ke

. >> do you differentiate between pfizer -- >> and merck -- i think they all sort of fall into very similarategoriries. when you look at what it's trading at on a pe ratio right now, that looks scary. they have this incredible pine line. and a lot of these names go into the generic area as well. huge upside. >> one extra thing about pfizer, they have the ceo who's probably going to split the company up over the next year or two. that's definitely a value on locking action. >> let's talk about the market quickly. we are counting down to stan fisher's speech at the economic club in new york city. he of course the vice chair of the fed. you do have stocks today higher across the board. well, the nasdaq is down. we are near historic highs. first back to back up days for stocks since february. so it's been a while. i want to go to steve right now for these comments that stanley fisher's making today. >> an increasing of federal fund rate is likely before the year-end. so says stanley fisher who says the approach of liftoff reflects the significant progress made in the dual mandate. when will it

the ceo of merck, which is arguably the most pharmaceutical company is a black man, the ceo of americanrestigious companies in america, is a black man. there have been many others in other industries. i think collectively, people in the entertainment industry have to start thinking, hey, we have to change this. we have to promote people in part because they come from different backgrounds. because we need to reflect the audience better. that's going to make economic sense for us. >> i think the other thing you're going to see is the whole -- the kind of cartel of cultural gatekeepers is coming apart anyway, right? >> i think there's going to be a little bit of a shakeup. you're asking folks to essentially have jobs for folks in senior positions, and decision-making decisions that don't look like them. that's going to be a tough thing for some people to take. >> gavin and ty, thank you both. "the rachel maddow show" starts right now. >> thank you, chris. and thanks to you at home for staying with us for the next hour. we have breaking news to report tonight involving new details reported

i think merck just announced the big buyback. j & happens tomorrow between 2:00 and 4:00. i'm not kidding. you like to think it's safe to go back to retail but the retailers are considered momentum names. let's give them a couple of days. actually reports a terrific number. just last night stock goes higher and then manages to plummet 12%. that's another griddle group. plus, you need to know that the analysts on wall street are now about to become your enemy. many of these analysts have been riding momentum wave right look with the investors. we should call them now flippers, right, who wanted to let everything ride and didn't want to take anything off the tables. that's how the analysts work. they're being called into the research directors office right now, and they're saying hey, listen you got to do some downgrading. we cannot stay positive on all these biotechs or industrial names in this environment, the environment being one of of course, panic not on analysis. bomb lun, not only do the bulls have no leadership worth following. unless you want to be led by kraft cha

merck has a drug, all of which allow the immune system to kill cancer cells.erri: this is such great news for some families out there or potentially will be. if this works, there seems to be a lot of excitement and hope around it, how long would it take to become ubiquitously used? how fast could people get this in the hands of doctors? >> the two new drugs that are fda approved are already in the hands of doctors. all these have fast-track designations by the fda. and, personally with my own patients i'm seeing things that i never thought i would see. gerri: all right? >> as an oncologist with new drugs. gerri: positive not negatives. >> positive, dramatic positive. gerri: all right. goodness, i'm so shocked by this and so amazed. why didn't we think of this before? >> we actually did think of it. it just took decades to develop. gerri: we used radiation chemotherapy, right? now the tests we're talking about at duke university, which is a very advanced university with cancer research and medical research generally, they have had some negative results. tell me

look at merck's buyback look at the kraft deal. you know, i don't know how much that adds up to, $30 billion, $40 billion we're talking about, and we're seeing the dow giving up 200 points. what do you make of it? >> kelly, i think we have to take a look at the calendar. something people aren't talking about today is the fact that we are getting very close to the end of the quarter. now, what does that mean for us? well, the japanese have got four days to settle stocks. they have t plus four. we have t plus three. a lot of what you're seeing today is a large footprint from what looks like profit taking. they're selling everything across the board. if you look at what they're buying, they're buying whatever they were short and that would be oil. so all of that tells me this is really end of the quarter type of action. the real question is what we see happen going into the beginning of the next quarter. remember, one of the xhings that worries me is that we're entering a very difficult time for stocks. look, you don't hear me get cau

puts company well ahead of rivals merck and roche into the kind of marketing for this kind of productz: coming up one major automaker is warning potential buyers of some of its deal remembers cheating customers? next we'll tell you what you need to look out for here. david: also a massive challenge to president obama's health care law goes before the supreme court. can obamacare survive another tweak? the very latest from d.c. coming next. ♪ at mfs, we believe in the power of active management. every day, our teams collaborate around the world, to actively uncover, discuss and debate investment opportunities. which leads to better decisions for our clients. it's a uniquely collaborative approach you won't find anywhere else. put our global active management expertise to work for you. mfs. there is no expertise without collaboration. we're reinventing inhow we do business, so businesses can reinvent the world. from pharmaceuticals to 3d prototyping, biotech to clean energy. whether your business is moving, expanding or just getting started... only new york offers you zero taxes for 10

you have traditional pharma companies like merck and ely lilly. when the dollar depose higher these companies get sold sold, sold. but then there's regeneron, up another 16 points today off its new cholesterol drug. ors or esperrion. positive clinical trial data on that cholesterol pill sent the stock soaring 29% today. an astonishing move. esperion tweeted it was going to come on, but canceled at the last minute because it filed an equity offering to take advantage of the stock's strength. then there's activist a giant drug company that closed on its acquisition of cramer fave allergan earlier today. the key thing you know about activist, it's a growth plan that's not known by the same rules that pfizer or lily play for, which is why it rallied up $2.50 why the old line pharmas didn't do so hot. now, again, before this year before this year started, we didn't see this kind of disparity within various groups. it was very rare to see a biotech diverge from the older drug companies, it used to lead them up. but that's not the norm in 2015. we're bac

i'm talking about ibm, ge, mcdonald's, verizon, at&t, caterpill caterpillar, procter & gamble, coke, merckjohnson & johnson is close, is the market in trouble? >> the market is just trying to find their way around right now because we are fixated on everything that the fed is trying to at least give us this transparency, and yet how transparent are they? i mean right now we're sitting at the desk, we feel patience coming out, something else will probably res place it and that will buy us a little more time. that's what we continue to do is buy time to see if the economy can get better. are there areas of the market that i would be concerned about. absolutely. other areas of the market that have been performing extremely well? absolutely. so it really depends right now, scott, where you are and it's been this rotation that we've been seeing time and time again over the last several quarters where the rotation out of some of the weaker -- while they were stronger performers into areas that had been weaker, and that's been the transition. but, those energy names are the names that are not get

. >> i'm the co-inventor of a rotavirus vaccine, a vaccine that i made in collaboration with merck, and it's a vaccine which has caused a dramatic decrease in this country in hospitalization and has caused already a dramatic decrease in hospitalization and death in some countries in the developing world. i'm enormously proud of that. i would argue that i have an expertise in rotaviruses and... >> but you also financially benefit from that vaccine. >> it's-it's... i know this isn't going to sell. but it doesn't matter. it doesn't matter whether i financially have benefited or not. the only thing that mattered is, did the vaccine that we created at children's hospital of philadelphia do what it was claimed to do? has it prevented hospitalization and suffering and death? and the answer to that question is yes. >> it's a mistake that we have a vaccine against rotavirus, the vaccine that paul offit helped to develop. in the third world, maybe people are dying of rotavirus, but in this country, you have to do back flips to show a death toll of people from rotavirus. >> well, one of the bitter

we're following a developing story and so is good morning merck. of shootings that terrorized the nation's capitol. karen. >> rain, freezing rain up to the north, snow out to the west. we'll all be dealing with that. we have a new model run that just dmaim with future tracker 6. i'll show you how long that lasts when "action news" comes right back the world is filled with air. but for people with copd sometimes breathing air can be difficult. if you have copd, ask your doctor about once-daily anoro ellipta. it helps people with copd breathe better for a full 24hours. anoro ellipta is the first fda-approved product containing two long-acting bronchodilators in one inhaler. anoro is not for asthma. anoro contains a type of medicine that increases risk of death in people with asthma. it is not known if this risk is increased in copd. anoro won't replace rescue inhalers for sudden copd symptoms and should not be used more than once a day. tell your doctor if you have a heart condition, or high blood pressure. tell your doctor if you have glaucoma, pros

shares of merck are in the green after the company increased its stock repurchase program to $10 billionat stock is up by about 1%. meantime shares of tesla slipping after getting downgraded to underperform at clsa. the firm is citing a risk to near term earnings from lower model x margins and that is bringing tesla shares down by about 3.5%. >>> coming up, as we told you at the top of the hour, a great lineup here for you on "squawk alley." sam altman from y begin nater will tell us why some of the bubble talk in silicon valley is a bit overblown. plus, top vc and early twitter investor chris sacca will walk us through the huge move in that company's stock, up over 40% this year alone. and finally, hows the documentary is changing the world of netflix. filmmaker ken burns is with us to break it down "squawk alley" is back in a minute. barbara just bought a bike. she wrote a tweet about it. you can't learn much from that. but take data from millions of tweets, combine that with your company's supply chain and sales data. apply ibm analytics and expertise, and all of a sudden, you can lea

merck shares getting a boost. the board authorizing additional share buyback up to $10 billion. margins. starwood downgraded from neutral to buy at suntrust analysts pointing to greater exposure to the lumber market. lumber liquidators trading higher. the safety commercial will hold a call at 10 a.m. eastern time on the safety concerns raised in the recent "60 minutes" segment. nationstar mortgage under pressure april secondary stock offering of 17.5 million. lexmark is buying kofax, it's $1 billion deal overall. 47% premium. hertz, received a notice it is out of compliance with the exchanges listing requirements. the reason late filing of its annual report what happen you need to be watching in today's trading session. some of the new york yankees hitting a social media home run re-creating a classic baseball movie. we've got the details when "squawk box" returns. elieve in the power of active management. our teams collaborate around the world, which leads to better decisions for our clients. put our global active management expertise to work for you. mfs. there is no expertise